US 12247226
Cellular reprogramming using temporal and transient plasmid vector expression system
granted A61KA61K35/12
Quick answer
US patent 12247226 (Cellular reprogramming using temporal and transient plasmid vector expression system) held by Fate Therapeutics, Inc. expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61K, A61K35/12